Trend of salvage treatment in diffuse large B cell lymphoma in the outpatient chemotherapy era

Patients with diffuse large B cell lymphoma (DLBCL) who have failed to achieve complete remission with first-line therapy can subsequently receive salvage therapy. However, there is no definite consensus on the use of salvage therapy, and little information on the optimal treatment regimen. The pres...

Descripción completa

Detalles Bibliográficos
Autores principales: Nakaya, Aya, Fujita, Shinya, Satake, Atsushi, Nakanishi, Takahisa, Azuma, Yoshiko, Tsubokura, Yukie, Saito, Ryo, Konishi, Akiko, Hotta, Masaaki, Yoshimura, Hideaki, Ishii, Kazuyoshi, Ito, Tomoki, Nomura, Shosaku
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2019
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6826265/
https://www.ncbi.nlm.nih.gov/pubmed/31692990
http://dx.doi.org/10.3892/mco.2019.1930

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6826265/
https://www.ncbi.nlm.nih.gov/pubmed/31692990
http://dx.doi.org/10.3892/mco.2019.1930

Ejemplares similares